GGrantIndex
← Leaderboards

Alan D Marmorstein

Cleveland Clinic Foundation

$7,661,857
Attributed
$7,661,857
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $954.6K · FY200519
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$7,661,857 · 5

By mechanism

R01$6,434,690 · 2
R03$451,958 · 1
U01$397,500 · 1
R56$377,709 · 1

Top collaborators

No co-investigators on record.

Most similar at Cleveland Clinic Foundation

Same institution · by research overlap

Others in their field

Top investigators on “Macular Degeneration

Research focus

Macular DegenerationBlindnessElectroretinographyCellsAffectProteinsExhibitsMouse ModelGenesGene ExpressionKnock-OutPreventVisionHuman TissueRetinal Pigment EpitheliumAnionsGoblet CellsHistopathologyTreatment StrategyBicarbonatesPhysiologyFunctional DisorderColonLight

Grant awards (23)

Preclinical testing of iPSC derived retinal pigment epithelium to treat macular degeneration$397,500
U01 · FY2019 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$350,595
R01 · FY2015 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$350,595
R01 · FY2014 · EY · contact PI
Bestrophin and retinal disease$440,713
R01 · FY2013 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$306,851
R01 · FY2013 · EY · contact PI
Bestrophin and retinal disease$76,258
R01 · FY2013 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$52,961
R01 · FY2013 · EY · contact PI
Bestrophin and retinal disease$575,844
R01 · FY2012 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$378,750
R01 · FY2012 · EY · contact PI
Bestrophin and retinal disease$572,056
R01 · FY2011 · EY · contact PI
Bestrophin and Retinal Disease$377,709
R56 · FY2009 · EY · contact PI
Bestrophin and Retinal Disease$359,234
R01 · FY2008 · EY · contact PI
Bestrophin and Retinal Disease$366,565
R01 · FY2007 · EY · contact PI
Bestrophin and Retinal Disease$368,629
R01 · FY2006 · EY · contact PI
Bestrophin and Retinal Disease$376,458
R01 · FY2005 · EY
A New Method for Retinal Imaging$150,500
R03 · FY2005 · EY
Bestrophin and Retinal Disease$376,250
R01 · FY2004 · EY
A New Method for Retinal Imaging$150,500
R03 · FY2004 · EY
BESTROPHIN AND RETINAL DISEASE$377,291
R01 · FY2003 · EY
New Method for Retinal Imaging$150,958
R03 · FY2003 · EY
BESTROPHIN AND RETINAL DISEASE$401,640
R01 · FY2002 · EY
BESTROPHIN AND RETINAL DISEASE$358,000
R01 · FY2001 · EY
BESTROPHIN AND RETINAL DISEASE$346,000
R01 · FY2000 · EY